QuantHealth Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 87

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $45M

  • Investors
  • 20

QuantHealth General Information

Description

Developer of artificial intelligence-based drug development data software designed to conduct patient-centric drug simulations to accelerate and de-risk drug development. The company's software combines data points from across the clinical and drug development spectrum and predicts patient response to both approved and novel therapies, allowing pharma and biotech customers to run variations of their clinical trials to improve the trial design and increase the probability of trial success, enabling healthcare industry in the discovery of new clinical opportunities and improve strategies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Derech Menachem Begin 132
  • Azrieli Triangle Tower
  • Tel Aviv
  • Israel
+972
Primary Industry
Other Healthcare Technology Systems
Corporate Office
  • Derech Menachem Begin 132
  • Azrieli Triangle Tower
  • Tel Aviv
  • Israel
+972

QuantHealth Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QuantHealth Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 04-Aug-2026 $45M Completed Generating Revenue
4. Early Stage VC (Series A) 30-Aug-2023 Completed Generating Revenue
3. Accelerator/Incubator 18-Dec-2022 Completed Generating Revenue
2. Seed Round $2.4M $5M Completed Generating Revenue
1. Seed Round 26-Oct-2022 $2.6M $2.6M Completed Generating Revenue
To view QuantHealth’s complete valuation and funding history, request access »

QuantHealth Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-2
Seed-4
Seed-3 142,356 $0.010000 $7.17 $7.17 1x $7.17 5.33%
Seed-1 45,141 $0.010000 $4.43 $4.43 1x $4.43 1.69%
To view QuantHealth’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

QuantHealth Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of artificial intelligence-based drug development data software designed to conduct patient-centric drug simul
Other Healthcare Technology Systems
Tel Aviv, Israel
87 As of 2026

Trieste, Italy
 

Lyon, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

QuantHealth Competitors (2)

One of QuantHealth’s 2 competitors is InSilicoTrials, a Venture Capital-Backed company based in Trieste, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSilicoTrials Venture Capital-Backed Trieste, Italy
Nova in Silico Venture Capital-Backed Lyon, France
You’re viewing 2 of 2 competitors. Get the full list »

QuantHealth Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

QuantHealth Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
ArtofIn Venture Capital Minority
Esplanade Healthtech Ventures Venture Capital Minority
NewHealth Ventures Venture Capital Minority
Nova Capital (Italy) Growth/Expansion Minority
Qumra Capital Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

QuantHealth FAQs

  • When was QuantHealth founded?

    QuantHealth was founded in 2020.

  • Where is QuantHealth headquartered?

    QuantHealth is headquartered in Tel Aviv, Israel.

  • What is the size of QuantHealth?

    QuantHealth has 87 total employees.

  • What industry is QuantHealth in?

    QuantHealth’s primary industry is Other Healthcare Technology Systems.

  • Is QuantHealth a private or public company?

    QuantHealth is a Private company.

  • What is QuantHealth’s current revenue?

    The current revenue for QuantHealth is .

  • How much funding has QuantHealth raised over time?

    QuantHealth has raised $66.7M.

  • Who are QuantHealth’s investors?

    ArtofIn, Esplanade Healthtech Ventures, NewHealth Ventures, Nova Capital (Italy), and Qumra Capital are 5 of 20 investors who have invested in QuantHealth.

  • Who are QuantHealth’s competitors?

    InSilicoTrials and Nova in Silico are competitors of QuantHealth.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process